Syfovre approval for geographic atrophy tops retina news in 2023

Healio’s top retina items last year included the FDA approvals of Syfovre for geographic atrophy and Eylea HD for wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.
Check out the most popular retina/vitreous items from 2023 below.
FDA approves Syfovre – first treatment for geographic atrophy, a leading cause of blindness
Apellis Pharmaceuticals announced the FDA approved its product Syfovre, also known as pegcetacoplan injection, for the treatment of geographic atrophy secondary to age-related macular degeneration. Read more.
FDA approves Eylea HD

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart